Vasopressin V2 Receptor Antagonist

Name
Vasopressin V2 Receptor Antagonist
Accession Number
DBCAT003559
Description

Not Available

Drugs
DrugDrug Description
TolvaptanA selective vasopressin V2-receptor antagonist to slow kidney function decline in patients at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). Also used to treat hypervolemic and euvolemic hyponatremia.
Drugs & Drug Targets
DrugTargetType
TolvaptanVasopressin V2 receptortarget
TolvaptanCytochrome P450 3A4enzyme
TolvaptanP-glycoprotein 1transporter
TolvaptanVasopressin V1a receptortarget